INTEGER HOLDINGS CORPORATION – Trademark Portfolio
Entity Type: 03
INTEGER HOLDINGS CORPORATION holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 3 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include PRESTIGE and COREGUARD. The owner is based in CLARENCE, NY.
10000 WEHRLE DRIVE
CLARENCE, NY 14031
Showing of trademarks Trademarks
Trademark Classifications
INTEGER HOLDINGS CORPORATION's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does INTEGER HOLDINGS CORPORATION have?
INTEGER HOLDINGS CORPORATION has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 2 cancelled.
What trademark classes does INTEGER HOLDINGS CORPORATION file in?
INTEGER HOLDINGS CORPORATION files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are INTEGER HOLDINGS CORPORATION's most well-known trademarks?
INTEGER HOLDINGS CORPORATION's registered trademark portfolio includes well-known marks such as PRESTIGE and COREGUARD. These are among 2 currently registered trademarks in the portfolio.
What is INTEGER HOLDINGS CORPORATION's trademark registration success rate?
INTEGER HOLDINGS CORPORATION has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.